The Potential of C-MyC as a Molecular Target

Syed Rahman

“Our results demonstrate an unsuspected link between the cancer-causing abilities of some cells and abnormal circadian and metabolic rhythms, which we surmise to be advantageous for cancer.” -Chi Van Dang (Director of the Abramson Cancer Center)

Cancer is defined as essentially uncontrolled cell division in abnormal human cells. The current treatment for many cancers is attempting to physically remove the cancer cells that have formed—what are seen as tumors, large and dense cell masses. Additionally, cocktails of chemotherapy treatments are also used including cytotoxic drugs such as doxorubicin. However, since these treatment options are very dangerous for the patient (such as from killing healthy cells) and are not completely remissive of the cancer, a great deal of research is being done into trying to find other molecular targets to target via drugs. Moreover, these molecular targets are simply proteins or genes in cancer cells that play a role in cellular processes that impact or are impacted by certain cancers. Therefore, it is believed that these proteins and genes can be targeted via drugs to indirectly impact the cancer itself or at least its symptoms. C-myc is a gene that has been researched and found to impact a variety of cellular process that cancer impacts or impacts cancer, such as cellular aging, cellular biorhythms, programmed cell death, and even interactions with other cancer causing genes in the cell as a whole.

C-myc is a protein transcription factor that has the ability to activate and repress target genes in the genome. Specifically, it is a basic helix-loop-helix leucine zipper transcription factor. It was discovered as the homolog of an oncogene associated with avian retroviruses and has been the subject of many studies involving a variety of cellular processes such as growth control and cellular differentiation. Recently, c-myc has been widely researched in a variety of cancers (Hoffman & Liebermann 2008). This is because many of its target genes control cellular processes that are commonly affected in cancers, such as cell cycle control and protein synthesis. Moreover, it has been shown that a variety of human cancers coincide with chromosomal abnormalities that in term deregulate c-myc protein, thus showing a possible way to regulate its levels in the body (Hoffman & Liebermann 2008). Overall, since c-myc can impact cancer in a variety of ways inside the cell (such as being important in apoptosis) and can be regulated, it seems to be an interesting topic to investigate as a potential molecular target.

C-myc functions as a transcriptional regulator by binding to a basic helix-loop-helix protein called MAX. Other partners such as Mx1 and MAD join c-myc as well, but MAX remains the most significant member of the complex that forms with c-myc. This c-myc and MAX complex eventually interacts with transcriptional coactivators and induces repression of a variety of other genes (Hoffman & Liebermann 2008). This complex is known to have a binding site on the p21 core promoter, another oncogene in cancer(Hoffman & Liebermann 2008). Therefore, it seems possible that c-myc can regulate other genes that directly affect other cancers. This could potentially be taken advantage of in the clinical setting.

C-myc has also exhibited a severe impact on cellular apoptosis, or programmed cell death. The study done by Askew employed myeloid progenitor cells which depend on interleukin 3 (IL-3) to grow and survive. When IL-3 was withdrawn from the cells, the level of c-myc was downregulated and cells became arrested in the G0 (or resting) phase of the cell cycle. These cells eventually underwent apoptosis (Askew Et. Al. 1991). Additionally, it was also found that enforced c-myc expression accelerates the apoptotic response as compared to IL-3 withdrawn cells that did not have enforced c-myc expression (Askew Et. Al. 1991). Thus, there is a correlation between c-myc levels and cellular death. This has been shown to happen through crosstalk with another gene present in many cancers called p53, a tumor suppressor gene which causes apoptosis in response to many different types of stimuli. C-myc has been shown to induce expression of the ADP ribosylation factor (ARF) protein, which will in turn increase the amount of p53 protein in the cell. Once again we see a crosstalk between c-myc and another gene that is important in regulating cancer, but also the apoptosis or death of cancer cells. This identifies c-myc as a critical gene in between other cancer causing genes that can be regulated externally to potentially even go as far as to kill cancer cells. Thus, it seems very clear that c-myc has a potential role in mediating a variety of other target genes in cancers that are known to have some role in cellular apoptosis and cell cycle state (Hoffman & Liebermann 2008).

Thus, there is oncogenic potential for c-myc as a target to directly impact a variety of pathways involved in oncogenesis. Additionally, it has also been shown to have an important role in impacting normal 24- hour rhythms in cancer cells, called circadian rhythms (University of Pennsylvania School of Medicine). It has recently been found that c-myc cancers have altered circadian rhythms in cells through the upregulation of the “clock” protein known as REV-ERBa (Altman et al., 2015) [Figure 1]. This lowers the expression of another protein known as BMAL1.

It is interesting because it has been shown that higher REV-ERBa expression and lower BMAL1 expression predicts worse clinical outcome for neuroblastoma patients in a clinical study done in The Children’s Hospital of Philadelphia and the University of Cologne in Germany with a sample size of survival data from over 740 patients (University of Pennsylvania School of Medicine 2015). Neuroblastomas are a very malignant tumor made up of neuroblast cells usually found on the adrenal glands of the kidney. This has the potential of being very useful in treating these cancers since they have a very poor clinical outcome. The potential of using c-myc as a molecular target is seen from the unusual circadian rhythms to affect the amount of REV-ERBa protein in the cell, which has been shown to affect neuroblastoma patient prognosis through some unknown mean (Altman Et. Al. 2001). Overall, there seems to be some potential in impacting clinical performance by affecting the role that c-myc has in various pathways.

Finally, c-myc has also been shown to affect the formation of telomeres in human cells. It has been shown that c-myc expression stimulated telomerase activity in human mammary epithelial cells that normally lack it. This leads to the possibility that one of the reasons that c-myc is prone to cause tumors and be deregulated in a variety of cancers is its ability to induce telomerase since tumor cell lines are almost all telomerase positive (Wang Et. Al. 1998). This just leads to another example of how it is possible for c-myc to affect the cell in a way that would in turn affect the progression of cancers. If this can be taken advantage of clinically, cancer treatments might be significantly improved.

Overall, c-myc has the potential to be investigated as a target for many different pathways in cancer. Its role in telomerase induction, circadian rhythms, and interplay with other cancer causing genes suggests ways for this gene to impact cancers. It is possible that drugs can affect the expression of the c-myc gene in different ways (such as overexpression or underexpression) in order to impact these roles and potentially treat certain cancers in a more effective way. However, much more research needs to be done in order to see the efficacy of c-myc as a potential target in treating cancers and identifying the particular type of repressor or drug that will affect its expression.

Input your search keywords and press Enter.

1500mg cbd oil what cbd oil really works cbd oil vitamin shoppe cbd queen strain cbd oil fibromyalgia pg free cbd oil what is hemp cbd oil zatural cbd oil reviews just cbd store coupon cbd oil how many times a day cbd without thc for anxiety cbd business bank account cbd pain cream near me cbd oil for sale in fayetteville nc cbd oil france resq organics cbd oil long trail cbd seltzer cbd oil yakima how much cbd should i smoke cbd oil store event cinemas auckland cbd pure cbd oil vs hemp oil cbd private castle 1 cbd 3 thc fioria cbd how often take cbd oil veteran cbd oil cbd oil illinois law cbd oil in tx is cbd oil legal in mass cbd oil dispensaries in visalia quartz cbd review amazon pay cbd oil cbd burlington vt

extenze supplement comparison erectile dysfunction drugs male enhancement bangkok supplements for size foods for male enhancement penis enlargement surgery lubbock bravado male enhancement pill best stamina sex pills over the counter alpha king male enhancement top male enhancement pills that work online generic pills do extenze pills really work what supplements help ed medicine side effects checker erectile dysfunction drugs not working animal supplement side effects pills price penis enlargement pills ron prescription pills pictures best male sex pill chili peppers and penis enlargement best male enhancement pills 2020 gnc the best men over the counter sex pills good vitamin supplements e 61 blue pill male sex enhancement pills south africa cocktail pills best pills for penis enlargement tirel chinese male enhancement pill gold black ball supplements to poerkan very effective male enhancement pills cree male enhancement reviews libido boosters men ed white pills

haze vape voopoo drag custom screen vape rda kit freemax mesh pro sub ohm tank what is pg vape cal state vape premium vape supply coupons guardian iii smok old school vape naked hawaiian dance ecig liquid flavor storage naked mango vape juice bamskilicious vape juice smok alien 220w tc battery lemon bar vape juice alpha vape e cigarette mechanical mods list smok stick v8 price e cigarette regulation date vape shop nashville vaping research 2018 fuel wheels vapor best temp for vaping oil twitch vaping on stream vaper kits wax vape pen near me all smok tanks liquid to vapor voopoo too coils nike tennis shoes smok nano coils mag vape uwell valyrian revolutionary sub ohm tank 5ml us stock obsession vape juice

supplement to lose weight best weight loss supplement with capsimax lose weight indian diet chart weight loss no meat diet diet to lose weight fast menu workout weight loss pills best rapid weight loss diets can you lose weight on the paleo diet blood group diet for weight loss 1200 calorie 7 day diet plan for weight loss garcinia weight loss pills how to take lipozene weight loss pills reviews average weight loss on hmr diet weight loss diet teas diet how long before weight loss diet doc weight loss cost how much does diet matter for weight loss safest diet plan weight loss weight loss pills and shakes weight loss supplement claim best weight loss pills for me weight loss pills family dollar weight loss pills bad for you nutrition supplement for weight loss will losartan interact weight loss pills keto tone pills gnc trinidad weight loss pills vegan diet for weight loss fast natural vitamin supplements for weight loss vegetarian diet plan lose weight keto diet percentages for weight loss keto diet easy recipes philippines journaling diet 10 weight loss in 6 mos folholskin weight loss pills